29 October 2021
Following our legal advice for AstraZeneca on the importation of the first batch of AstraZeneca’s Covid-19 vaccines into Vietnam, LNT & Partners is proud to advise VABIOTECH, SOVICO and DANSON on the Sputnik V Covid-19 vaccines production license and distribution project in Vietnam.
VABIOTECH is the largest vaccine manufacturer and supplier in the National Expanded Immunization Program and the Sputnik V vaccines produced by VABIOTECH are set to be used in the national vaccination program, furthering Vietnam’s efforts in curbing the spread of Covid-19. VABIOTECH’s President, Dr. Do Tuan Dat, commented, "we are pleased to announce the successful production of the first batch of Sputnik V vaccines in Vietnam. The Russian experts have analyzed and evaluated the batch for compliance with regulatory requirements. This first batch is expected to help the Vietnamese people access a new source of quality vaccines, contributing to the fight against Covid-19."
LNT team led by Corporate/M&A partner Thuy Nguyen advised our clients on various legal aspects of this cross-border collaboration, from the licenses required for the production of Sputnik V vaccines, project financing, vaccine supply during the first stage of cooperation, to the distribution of the vaccines in Vietnam and potential abroad in the future.
Press release: LINK
For further information, please contact:
NGUYEN Xuan Thuy, Partner, LNT & Partners
thuy.nguyen@lntpartners.com
